Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Chongqing General Hospital /ID# 232305

Chongqing, Chongqing Municipality 400013, ChinaNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Crohn's disease

Running trials

Active, not recruiting
Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)
NCT04524611· Phase 3· AbbVie· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Chongqing General Hospital /ID# 232305: trial site – Frontlight Research